Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7603167

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
5,007,000,000 JPY
4,046,000,000 JPY
5,786,000,000 JPY
4,685,000,000 JPY
Non-operating income
Non-operating income
677,000,000 JPY
83,000,000 JPY
798,000,000 JPY
70,000,000 JPY
Non-operating expenses
Non-operating expenses
115,000,000 JPY
170,000,000 JPY
137,000,000 JPY
171,000,000 JPY
Ordinary profit (loss)
5,569,000,000 JPY
3,960,000,000 JPY
6,447,000,000 JPY
4,585,000,000 JPY
Extraordinary income
Extraordinary income
0 JPY
1,929,000,000 JPY
Extraordinary losses
Extraordinary losses
352,000,000 JPY
0 JPY
25,000,000 JPY
0 JPY
Profit (loss) before income taxes
5,216,000,000 JPY
3,959,000,000 JPY
8,352,000,000 JPY
4,585,000,000 JPY
Income taxes - current
1,630,000,000 JPY
45,000,000 JPY
1,847,000,000 JPY
60,000,000 JPY
Income taxes - deferred
-346,000,000 JPY
-5,000,000 JPY
374,000,000 JPY
8,000,000 JPY
Profit (loss)
3,919,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,932,000,000 JPY
3,919,000,000 JPY
4,516,000,000 JPY
4,516,000,000 JPY
6,130,000,000 JPY
4,516,000,000 JPY
4,516,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.